Platelet activating factor (PAF) antagonists: development of a highly potent PAF antagonist, TCV-309

Adv Prostaglandin Thromboxane Leukot Res. 1991:21B:943-6.
No abstract available

MeSH terms

  • Animals
  • Azepines / pharmacology
  • Humans
  • Isoquinolines / chemical synthesis
  • Isoquinolines / chemistry
  • Isoquinolines / pharmacology*
  • Molecular Structure
  • Niacinamide / analogs & derivatives
  • Niacinamide / chemical synthesis
  • Platelet Activating Factor / antagonists & inhibitors*
  • Pyridinium Compounds / chemical synthesis
  • Pyridinium Compounds / chemistry
  • Pyridinium Compounds / pharmacology*
  • Rabbits
  • Rats
  • Structure-Activity Relationship
  • Tetrahydroisoquinolines*
  • Triazoles / pharmacology

Substances

  • Azepines
  • Isoquinolines
  • Platelet Activating Factor
  • Pyridinium Compounds
  • Tetrahydroisoquinolines
  • Triazoles
  • CV 6209
  • WEB 2086
  • Niacinamide
  • TCV 309